Literature DB >> 12769786

Drug-induced aseptic meningitis.

Eustachio Nettis1, Gianfranco Calogiuri, Maria Cristina Colanardi, Antonio Ferrannini, Alfredo Tursi.   

Abstract

Aseptic meningitis is a rare but well-recognized complication of drug therapy. The clinical presentation of drug-induced aseptic meningitis (DIAM) is distinct. Symptoms typically include fever, neck stiffness, headache, confusion, nausea and vomiting. The major categories of causative agents are non-steroidal anti-inflammatory drugs, antimicrobials and also intravenous immunoglobulins, monoclonal antibodies and vaccines. These drugs most commonly implicated as causes of aseptic meningitis act more likely through an immunological mechanisms. However, the exact pathogenetic mechanism of DIAM is still unknown. The diagnosis of drug-induced aseptic meningitis is difficult and infectious etiologies must be excluded. In some cases the diagnosis has been confirmed by rechallenging the patient with the suspected agent. In this case, informed written consent is necessary and rechallenge must be medically supervised both to document the response and to offer medical care and advice, if required. The outcome of DIAM is generally good, usually without long term sequelae.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12769786     DOI: 10.2174/1568008033340243

Source DB:  PubMed          Journal:  Curr Drug Targets Immune Endocr Metabol Disord        ISSN: 1568-0088


  8 in total

Review 1.  Intravenous immunoglobulin: adverse effects and safe administration.

Authors:  Hedi Orbach; Uriel Katz; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 2.  Headache attributable to nonvascular intracranial disorders.

Authors:  Mark Obermann; Dagny Holle; Steffen Naegel; Hans-Christoph Diener
Journal:  Curr Pain Headache Rep       Date:  2011-08

3.  Amoxicillin-induced aseptic meningoencephalitis.

Authors:  Radi Shahien; Vetaly Vieksler; Abdalla Bowirrat
Journal:  Int J Gen Med       Date:  2010-07-21

Review 4.  Is passive immunization for Alzheimer's disease 'alive and well' or 'dead and buried'?

Authors:  Gregory A Jicha
Journal:  Expert Opin Biol Ther       Date:  2009-04       Impact factor: 4.388

5.  Recurrent case of ibuprofen-induced aseptic meningitis in mixed connective tissue disease.

Authors:  Paras Karmacharya; Naba Raj Mainali; Madan Raj Aryal; Benjamin Lloyd
Journal:  BMJ Case Rep       Date:  2013-04-30

Review 6.  Chronic meningitis.

Authors:  Bruce A Cohen
Journal:  Curr Neurol Neurosci Rep       Date:  2005-11       Impact factor: 6.030

Review 7.  Intravenous Immunoglobulin-Induced Aseptic Meningitis-A Narrative Review of the Diagnostic Process, Pathogenesis, Preventative Measures and Treatment.

Authors:  Anna Kretowska-Grunwald; Maryna Krawczuk-Rybak; Malgorzata Sawicka-Zukowska
Journal:  J Clin Med       Date:  2022-06-21       Impact factor: 4.964

8.  Trimethoprim-Sulfamethoxazole-Induced Aseptic Meningitis: A New Approach.

Authors:  Sarah Elmedani; Asseel Albayati; Ndausung Udongwo; Mihir Odak; Sharif Khawaja
Journal:  Cureus       Date:  2021-06-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.